| Methylphenidate-Induced Visual Hallucinations. | |
| | |
MedLine Citation:
|
PMID: 21500140 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
An 11-year-old boy with attention deficit/hyperactivity disorder (ADHD) presented with visual hallucinations several years after starting methylphenidate (MPH). The hallucinations resolved upon discontinuation of the drug. Reports of toxic hallucinosis during treatment with MPH are rare. Although the pathogenetic mechanism is unclear, the occurrence of hallucinations may be explained by a chronic increase in synaptic dopamine. Clinicians should be aware of this possible rare adverse manifestation occurring at therapeutic doses. |
| | |
Authors:
|
M C Porfirio; G Giana; S Giovinazzo; P Curatolo |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-4-15 |
Journal Detail:
|
Title: Neuropediatrics Volume: - ISSN: 1439-1899 ISO Abbreviation: - Publication Date: 2011 Apr |
Date Detail:
|
Created Date: 2011-4-18 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8101187 Medline TA: Neuropediatrics Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
© Georg Thieme Verlag KG Stuttgart · New York. |
Affiliation:
|
Department of Neuroscience, Child Neurology Unit, Tor Vergata University, Rome, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Prenatal Magnetic Resonance Imaging Diagnosis of Molar Tooth Sign at 17 to 18 Weeks of Gestation in ...
Next Document: Fetal origin of brain damage in 2 infants with a COL4A1 mutation: fetal and neonatal MRI.